Back
Plus Therapeutics 10K Form
Sell
21
PSTV
Plus Therapeutics
Last Price:
1.70
Seasonality Move:
-15.5%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive PSTV News And Ratings
See the #1 stock for the next 7 days that we like better than PSTV
PSTV Financial Statistics
Sales & Book Value
| Annual Sales: | $224K |
|---|---|
| Cash Flow: | $-1.92M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $-0.30 |
| Price / Book: | 0 |
Profitability
| EPS (TTM): | -4.39000 |
|---|---|
| Net Income (TTM): | $-13.32M |
| Gross Margin: | $5.51M |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Plus Therapeutics Earnings Forecast
Key Plus Therapeutics Financial Ratios
- The Gross Profit Margin over the past 21 years for PSTV is 184.71%.
- The Selling, General & Administrative Expenses for PSTV have been equal to 4,570.54% of Gross Profit Margin.
- The Interest Expense is -2.97% of Operating Income.
- Per Share Earnings over the last 26 years have been positive in 19 years.
Plus Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | PSTV |
| CUSIP: | 72941H |
| Website: | plustherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
PSTV Technical Analysis vs Fundamental Analysis
Sell
21
Plus Therapeutics (PSTV)
is a Sell
Is Plus Therapeutics a Buy or a Sell?
-
Plus Therapeutics stock is rated a Sell
The current Plus Therapeutics [PSTV] share price is $1.67. The Score for PSTV is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.